Kiyoshi Okazuka, Nobuhiro Tsukada, Junichiro Nashimoto, Takao Yogo, Yui Uto, Kota Sato, Kanji Miyazaki, Mizuki Ogura, Yumiko Yoshiki, Yu Abe, Tadao Ishida, Kenshi Suzuki (Hematol., Japanese Red Cross Medical Center, Tokyo, Japan)

Junichiro Nashimoto¹, Yumiko Yoshiki¹, Nobuhiro Tsukada¹, Takao Yogo¹, Yui Uto¹, Kota Sato¹, Kanji Miyazaki¹, Mizuki Ogura¹, Yu Abe¹, Kiyoshi Okazuka¹, Tadao Ishida¹, Kenshi Suzuki² (1.Hematol., Japanese Red Cross Medical Center, Tokyo, Japan, 2.Myeloma Amyloidosis Center, Japanese Red Cross Medical Center, Tokyo, Japan)

Nagaaki Katoh, Akihiro Ueno, Yoshiki Sekijima (Department of Neurology and Rheumatology, Shinshu University, Matsumoto, Japan)

Shino Fujimoto¹, Hiroshi Kawabata¹, Yasufumi Masaki¹, Kazue Takai², Norifumi Tsukamoto³, Yasuhito Ishigaki⁴, Nozomu Kurose⁵, Masaru Kojima⁶, Shigeo Nakamura⁷, Tomohiro Kinoshita⁸, Sadao Aoki⁹ (1.Hematology and Immunology, Medicine, Kanazawa Medical University,Ishikawa , Japan, 2.Department of Hematology, Niigata City General Hospital, Niigata,Japan, 3.Department of Medicine and Clinical Science, Gunma University, Gunma, Japan, 4.Medical Research Institute, Kanazawa Medical University, Ishikawa, Japan, 5.Department of Pathology and Medicine, Kanazawa Medical University, Ishikawa,Japan, 6.Department of Diagnostic Pathology, Dokkyo University , Tochigi, Japan, 7.Department of Pathology and Biological Response, Nagoya University , Aichi,Japan, 8.Hematology and Cell Therapy Aichi Cancer Center Hospitai , Aichi,Japan, 9.Department of Pathophysiology, Niigata University of Pharmacy, Niigata, Japan)

Hideki Asaoku¹, Mitsuhiro Itagaki¹, Takeshi Okatani¹, Ryota Imanaka¹, Kohei Kyo¹, Tatsuji Mino¹, Yuta Katayama¹, Shinya Katsutani², Koji Iwato² (1.Dept Hematol, HRCH & ASH,Hiroshima, Japan, 2.Dept clinical laboratory, HRCH & ASH, Hiroshima, Japan)

Hitomi Kaneko^1,20, Hirohiko Shibayama^2,20, Hideo Yagi^3,20, Junya Kanda^4,20, Aya Nakaya^5,20, Satoru Kosugi^6,20, Toru Kida^6,20, Hirokazu Tanaka^7,20, Yuji Shimura^8,20, Shin-Ichi Fuchida^9,20, Yoko Adachi^10,20, Katsuya Wada^11,20, Miki Kiyota^11,20, Nobuhiko Uoshima^12,20, Kensuke Ohta^13,20, Takae Kohara^14,20, Tsuneyoshi Hamada^15,20, Masayuki Kobayashi^15,20, Hitoji Uchiyama^16,20, Takahiro Karasuno^17,20, Junya Kuroda^8,20, Kazunori Imada^1,20, Akifumi Takaori-Kondo^4,20, Chihiro Shimazaki^9,20, Yuzuru Kanakura^2,20, Masayuki Hino^18,20, Shosaku Nomura^19,20, Itaru Matsumura^7,20 (1.Department of Hematology, Osaka Red Cross Hospital, Osaka, Japan, 2.Department of Hematology and Oncology, Osaka Univ., Osaka, Japan, 3.Department of Hematology and Oncology, Nara Prefecture General Medical Center, 4.Department of Hematology and Oncology, Kyoto Univ., Kyoto, Japan, 5.Division of hematology, Kansai Medical University Medical Center, Osaka, Japan, 6.Department of Internal Medicine (Hematology), Toyonaka Municipal Hospital, Osaka, Japan, 7.Department of Hematology and Rheumatology, Kindai Univ., Osaka, Japan, 8.Division. of Hematology and Oncology, Kyoto Prefectural Univ., Kyoto, Japan, 9.Department of Hematology, JCHO Kyoto Kuramaguchi Medical Center, Kyoto, Japan, 10.JCHO Kobe Central Hospital, Department of Internal Medicine, Kobe, Japan, 11.Department of Hematology, Matsushita Memorial Hospital, Osaka, Japan, 12.Department of Hematology, Japanese Red Cross Kyoto Daini Hospital, Japan, 13.Department of Hematology, Osaka Saiseikai Nakatsu Hospital, Osaka, Japan, 14.Department of Hematology, Sakai City Medical Center, Osaka, Japan, 15.Hematology Div. Int. Med., Kyoto-Katsura Hospital, Kyoto, Japan, 16.Japanese Red Cross Kyoto Daiichi Hospital, Department of Hematology, Japan, 17.Department of Hematology, Rinku General Medical Center, Osaka, Japan, 18.Hematology, Osaka City University Graduate School of Medicine, Osaka, Japan, 19.First Department of Internal Medicine, Kansai Medical University, Osaka, Japan, 20.Kansai Myeloma Forum)